Testavan® (transdermal testosterone gel 2%) is a testosterone replacement therapy for adult male hypogonadism, when testosterone deficiency has been confirmed by clinical features and biochemical tests. Launched in 2018, Testavan® is formulated with F.A.S.T. (F.A.S.T. Advanced Skin Technology) absorption to enhance bioavailability of testosterone through the skin, and is administered using a hands-free applicator that may lower the risk of transference of testosterone skin residue from the patient to others. Testavan® is sold in over 20 countries worldwide, with plans to launch in a further 10+ countries.
Vitaros® (alprostadil cream) is the only topical cream that treats Erectile Dysfunction (ED). The treatment is a first line alternative for ED patients and especially patients who prefer local treatment or may not be candidates for oral PDE-5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil) due to medical constraints or concomitant medications. Vitaros® is sold in more than 15 countries worldwide including through its licensing partners.